评估急性呼吸窘迫综合征通气决策支持系统(DeVENT研究)——试验方案
DeVENT研究是一项多中心、国际、随机、对照、分配隐藏、开放、实用性临床试验,比较在急性呼吸窘迫综合征(ARDS)患者中应用Beacon Caresystem决策支持系统指导机械通气与常规治疗,以探究该系统能否在所有严重程度和阶段的ARDS中降低驱动压。
要点
- Beacon Caresystem是基于模型的床旁决策支持系统,利用数学模型根据患者生理状态建议通气设置。
- 试验比较该系统指导的通气与常规治疗,主要探讨驱动压的降低。
- 试验注册号NCT04115709,2019年10月4日注册,版本4.0。
核心结论
- 研究旨在探究Beacon Caresystem决策支持系统能否在所有严重程度和阶段的ARDS患者中降低驱动压。
研究设计与样本
- 多中心、国际、随机、对照、分配隐藏、开放、实用性临床试验,比较ARDS患者应用Beacon Caresystem指导的机械通气与标准常规治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The acute respiratory distress syndrome (ARDS) occurs in response to a variety of insults, and mechanical ventilation is life-saving in this setting, but ventilator-induced lung injury can also contribute to the morbidity and mortality in the condition. The Beacon Caresystem is a model-based bedside decision support system using mathematical models tuned to the individual patient's physiology to advise on appropriate ventilator settings. Personalised approaches using individual patient description may be particularly advantageous in complex patients, including those who are difficult to mechanically ventilate and wean, in particular ARDS. METHODS: We will conduct a multi-centre international randomised, controlled, allocation concealed, open, pragmatic clinical trial to compare mechanical ventilation in ARDS patients following application of the Beacon Caresystem to that of standard routine care to investigate whether use of the system results in a reduction in driving pressure across all severities and phases of ARDS. DISCUSSION: Despite 20 years of clinical trial data showing significant improvements in ARDS mortality through mitigation of ventilator-induced lung injury, there remains a gap in its personalised application at the bedside. Importantly, the protective effects of higher positive end-expiratory pressure (PEEP) were noted only when there were associated decreases in driving pressure. Hence, the pressures set on the ventilator should be determined by the diseased lungs' pressure-volume relationship which is often unknown or difficult to determine. Knowledge of extent of recruitable lung could improve the ventilator driving pressure. Hence, personalised management demands the application of mechanical ventilation according to the physiological state of the diseased lung at that time. Hence, there is significant rationale for the development of point-of-care clinical decision support systems which help personalise ventilatory strategy according to the current physiology. Furthermore, the potential for the application of the Beacon Caresystem to facilitate local and remote management of large numbers of ventilated patients (as seen during this COVID-19 pandemic) could change the outcome of mechanically ventilated patients during the course of this and future pandemics. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT04115709. Registered on 4 October 2019, version 4.0.
引用
- Patel B, Mumby S, Johnson N, et al. Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol. Trials. 2022. PMID: 35039050. doi:10.1186/s13063-021-05967-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。